With the Philadelphia Eagles headed to the NFL championship Sunday, one lucky print shop in our area is tasked with making ...

American depositary receipts (ADRs) of Novo Nordisk (NVO) jumped over 4% in pre-market trading this morning after reporting a healthy sales ...

LLY is reporting earnings tomorrow and the options market predicts major moves. PFP system shows bullish positioning and ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $732 billion, has been ...

Truist Securities updated their financial model for Eli Lilly and Company (NYSE:LLY), leading to an increased price target on the pharmaceutical giant's shares. The new price target is set at ...

MORGANTOWN — West Virginia University is shutting down its Division of Diversity, Equity and Inclusion following Gov. Patrick ...

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

Target’s rollback on diversity, equity and inclusion initiatives is raising questions about the retail giant’s philanthropic ...

Mediar Therapeutics is planning to launch a Phase 2 clinical trial in the first half of 2025 to test its IPF therapy MTX-463.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

The Liberal government has spent years touting its efforts to make tech giants pay. Now, those pieces of legislation could be ...